Caribou Biosciences Cash Flow Statement (2020-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-20.97M	-18.48M	-22.68M	-76.10M	-51.42M	-31.07M	-31.42M	-76.67M	-29.88M	-37.57M	-87.36M	-56.59M	-76.09M	-40.31M	-43.03M	-47.74M	-32.40M	-28.91M	-28.11M	-26.30M
Depreciation and Depletion (Quarter)	0.30M	-0.70M	0.30M	0.40M
Share-based Compensation (Quarter)	0.94M		26.25M	31.50M	20.31M	-14.53M	3.13M	3.58M	3.48M	3.56M	3.99M	4.74M	4.07M	3.91M	3.88M	3.13M	2.93M	2.74M	2.36M	2.48M
Deferred Taxes (Quarter)
Asset Writedowns and Impairment (Quarter)															9.20M	2.20M		0.05M
Cash from Operations (Quarter)	-14.97M	-21.39M	-21.67M	-21.87M	-22.38M	-25.04M	-27.94M	-15.19M	-28.79M	-21.38M	-37.20M	-32.87M	-32.66M	-35.47M	-36.73M	-28.26M	-25.22M	-20.79M	-26.98M	-22.80M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)		-0.05M	-0.33M	-0.12M	0.34M	0.90M	1.49M	2.10M	2.44M	-1.62M	1.54M	0.95M	1.22M	1.02M	0.45M	0.29M	0.23M	0.16M	0.27M	0.04M
Depreciation & Amortization (CF) (Quarter)	0.26M	0.27M	0.31M	0.36M	0.45M	0.51M	0.59M	0.62M	1.58M	0.74M	0.71M	0.86M	1.18M	1.18M	1.17M	1.17M	0.63M	0.68M	0.65M	0.62M
Change in Working Capital
Change in Receivables (Quarter)	0.58M	0.57M	-0.78M	0.15M	-0.13M	-0.20M	1.33M	-0.77M	0.37M	-0.98M	0.77M	-0.70M	-0.03M	0.08M	-0.18M	-0.02M	0.17M	-0.17M	0.16M	-0.02M
Change in Account Payables (Quarter)	-0.18M	0.29M	-1.92M	-1.64M	0.99M	-0.15M	1.50M	0.54M	-0.95M	0.73M	2.72M	-2.37M	-0.48M	-0.23M	1.40M	-0.63M	0.56M	1.92M	-2.22M	-0.42M
Change in Accured Expenses (Quarter)	3.85M	-0.57M	-0.01M	-0.01M	0.92M	1.04M	-4.14M	3.71M	3.28M	2.90M	-2.20M	4.97M	1.58M	-2.21M	-3.10M	0.69M	-1.11M	-2.82M	-2.65M	-0.74M
Other Working Capital Changes (Quarter)	2.61M	-2.44M	0.49M	-0.14M	0.01M	0.61M	-0.06M	-0.06M	-0.73M	-0.91M	0.21M	-0.05M	2.99M	0.78M	-0.47M	-0.34M	-0.93M	-1.93M	-0.52M	-0.05M
Investing Activities
Capital Expenditures (Quarter)	-0.24M	1.85M	0.72M	2.62M	1.35M	-3.47M	1.71M	2.87M	4.75M	2.28M	1.45M	-1.27M	0.20M	4.51M	1.04M	-0.97M	1.51M	-0.22M	0.07M	0.00M
Change in Acquisitions & Divestments (Quarter)			39.30M	59.71M	64.12M	89.74M	98.67M	72.36M	112.17M	54.99M	97.09M	107.80M	120.66M	71.94M	65.95M	56.67M	68.41M	61.79M	46.14M	39.45M
Cash from Investing Activities (Quarter)	-1.93M	-173.96M	-72.11M	-13.97M	-8.34M	1.17M	20.70M	11.06M	-68.48M	-31.47M	22.96M	21.20M	26.52M	15.93M	49.38M	24.04M	10.85M	17.97M	23.98M	18.94M
Financing Activities
Other financing activities (Quarter)	319.89M							17.45M	-17.45M	17.29M	0.67M	0.00M	0.24M	0.00M	0.47M		0.28M		0.47M
Cash from Financing Activities (Quarter)	322.68M	0.46M	0.99M	0.36M	0.65M	0.13M	1.64M	17.57M	135.13M	-0.04M	12.48M	0.13M	0.24M	3.86M	0.47M	0.01M	0.28M	4.07M	2.70M	17.94M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)							1.12M	-0.12M	-0.00M		11.33M			3.86M				4.07M	2.22M	17.92M
Additional items
Change in Cash (Quarter)	305.79M	-194.89M	-92.79M	-35.48M	-30.06M	-23.75M	-5.59M	13.45M	37.86M	-52.90M	-1.76M	-11.53M	-5.90M	-15.68M	13.12M	-4.22M	-14.06M	1.22M	-0.30M	14.09M
Free Cash Flow (Quarter)	-14.73M	-23.24M	-22.40M	-24.49M	-23.73M	-21.57M	-29.65M	-18.05M	-33.54M	-23.66M	-38.65M	-31.59M	-32.86M	-39.98M	-37.77M	-27.28M	-26.73M	-20.58M	-26.98M	-22.80M
Net Cash Flow (Quarter)	305.79M	-194.89M	-92.79M	-35.48M	-30.06M	-23.75M	-5.59M	13.45M	37.86M	-52.90M	-1.76M	-11.53M	-5.90M	-15.68M	13.12M	-4.22M	-14.09M	1.25M	-0.30M	14.08M

Research Tools

Datasets

Plans

Developers

Caribou Biosciences CRBU Cash Flow Statement (2020-2026)

Research Tools

Datasets

Plans

Developers

Caribou Biosciences CRBU Cash Flow Statement (2020-2026)

Create an account

Sign In

Reset Password